Search Articles — Sudonull

https://sudonull.com/accessible-datepicker-react-wcag-2-2

Create WCAG 2.2 AA DatePicker on React: AI code fixes, focus trap, aria-live assertive. For middle/senior dev. Tested on NVDA/VoiceOver. Full guide.

https://sudonull.com/solo-development-hail-to-the-rainbow-atomic-heart-quality

Learn how one developer created the AAA-project level game Hail to the Rainbow competing with Atomic Heart, and what lessons to draw from this case for gamedev.

https://sudonull.com/nwinfo-1-6-2-pc-diagnostics-updates

Explore changes in NWinfo 1.6.2: DMI fixes, AAM/APM API, PCH sensors. Portable tool for Windows. Download and test on your hardware.

https://sudonull.com/orbitaid-indian-satellite-refueling-technology-in-orbit

Indian startup OrbitAID is developing satellite refueling in orbit. SIDRP technology, AayulSAT mission. Market and prospects analysis. Learn more.

https://sudonull.com/theft-of-292m-from-kelp-dao-details-of-the-bridge-attack

Hacker withdrew 116,500 rsETH from the Kelp DAO protocol. Vulnerability in the cross-chain bridge, team response, and market implications. Read in the analytical article.

https://ymaho.com/aave-dao-funding-plan-25m-approved-for-defi-growth

Aave DAO just approved major funding for its dev team. Learn what this means for decentralization, DeFi users, and the future of crypto governance.

https://ymaho.com/kelp-hack-two-scenarios-of-aave-crisis

LlamaRisk analysts presented two scenarios for solving Aave's problems after the Kelp bridge hack of $293 million. Find out how this will affect the market and your assets.

https://ymaho.com/aav9-gene-therapy-for-sma-long-term-efficacy-study

A long-term study in Nature Communications confirmed the efficacy of optimized AAV9 gene therapy for spinal muscular atrophy. Learn about safety and treatment prospects.

https://ymaho.com/aav-gene-therapy-for-hofh-cholesterol-reduction-by-97-5-in-clinical-trial

New AAV8 gene therapy NGGT006 for homozygous familial hypercholesterolemia reduced LDL-C by 97.5% in 3 weeks. Effect persists for 52 weeks. Find out who is eligible for treatment.

https://ymaho.com/aave-and-bancor-key-governance-votes-in-defi-protocols

Analysis of Aave V4 votes on Arc and Bancor fee reductions. Learn how institutional DeFi is changing the crypto lending market. Read now.

https://ymaho.com/kelp-dao-hack-freezes-aave-withdrawals-what-happened

A $291M bridge exploit triggered a liquidity crunch on Aave, sparking $6.2B in withdrawals. Learn how the hack works and what it means for users.

https://ymaho.com/kelp-dao-and-aave-how-to-save-300-million-after-a-hacker-attack

Co-founder of DeFiLlama proposed three recovery scenarios for Kelp DAO and Aave after the hack. Learn what solutions the community is discussing and what this means for DeFi.

https://ymaho.com/targeted-therapy-for-usher-syndrome-1b-new-data-on-aavb-081

Interim data from phase 1/2 gene therapy AAVB-081 for Usher syndrome 1B: safety, efficacy, and prognosis. Learn about the dual AAV vector and treatment prospects.

https://ymaho.com/russia-registers-first-pertussis-vaccine-for-adults

Rostec created aAKDS-M — a cell-free vaccine for people 18+. Protects against diphtheria, pertussis, and tetanus for 10 years. Learn how the drug will replace imported Adacel and protect infants from deadly cough.

https://ymaho.com/ai-designed-viral-vectors-50-fold-increase-in-gene-delivery-to-the-brain

WhiteLab Genomics created AAV vectors with AI that deliver genes to the mouse brain 50 times more efficiently and accumulate less in the liver. Learn about the breakthrough in gene therapy.